Beta Drugs Limited has informed the Exchange regarding Corrigendum to Notice of Extra Ordinary General Meeting to be held on February 04, 2026
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited has filed a corrigendum, which is a correction or amendment to the original notice of its Extra Ordinary General Meeting (EGM). The EGM is scheduled to be held on February 4, 2026. The corrigendum likely addresses an error, omission, or clarification needed in the previously issued EGM notice. No specific agenda items or revised details were shared in this filing headline. Shareholders are advised to review the updated notice carefully before the meeting.
This is a procedural correction to an existing EGM notice and is unlikely to have a direct impact on the stock price. Shareholders should refer to the revised notice for accurate information on the resolutions to be discussed and voted on at the meeting.